Cargando…
Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems
Post-stroke depression (PSD) is the most common non-cognitive neuropsychiatric complication after stroke, and about a third of patients with stroke have depression. Although a great deal of effort has been made to treat PSD, the efficacy thereof has not been satisfactory, due to the complex patholog...
Autores principales: | Zhang, Meng, Bai, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818889/ https://www.ncbi.nlm.nih.gov/pubmed/35140618 http://dx.doi.org/10.3389/fphar.2022.821270 |
Ejemplares similares
-
Improved Resting-State Functional Dynamics in Post-stroke Depressive Patients After Shugan Jieyu Capsule Treatment
por: Yao, Guanqun, et al.
Publicado: (2020) -
Meta-analysis of Shugan Jieyu Capsule for depression in patients with coronary heart disease
por: Liu, Zhen, et al.
Publicado: (2023) -
Antidepressant Shugan Jieyu Capsule Alters Gut Microbiota and Intestinal Microbiome Function in Rats With Chronic Unpredictable Mild Stress -Induced Depression
por: Tan, Jingxuan, et al.
Publicado: (2022) -
Improving Depressive Symptoms of Post-stroke Depression Using the Shugan Jieyu Capsule: A Resting-State Functional Magnetic Resonance Imaging Study
por: Yao, Guanqun, et al.
Publicado: (2022) -
Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression
por: Li, Zhenzhen, et al.
Publicado: (2023)